Continuous Glucose Monitoring Device Market Size, Share, Growth, and Industry Analysis, By Type (Sensors and Transmitters & Receivers), By Application (TYPE1 Diabetes and TYPE2 Diabetes), and by Regional Forecast to 2033

CONTINUOUS GLUCOSE MONITORING DEVICE MARKET OVERVIEW

The global Continuous Glucose Monitoring Device Market size was USD 10.011 billion, with projections to grow to USD 23.64 billion by 2033 at a CAGR of 10.02% during the forecast period.

The market for Continuous Glucose Monitoring (CGM) devices is growing tremendously owing to the increasing prevalence of diabetes and the rising need for real-time blood sugar monitoring. It gives continuous recording on a glucose level so that it helps the diabetic manage his blood sugar better and minimize complications from improved accuracy, ease of access, and user friendliness which advancement in technology offers. Increased awareness, technology's innovations, and supportive criteria make households for the CGM market. Rising acceptance continued within CGMs worldwide; thus, happiness in the market is expected to scale up swiftly in the future.

COVID-19 IMPACT

Continuous Glucose Monitoring Device Industry Had a Positive Effect Due to the COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic boosted the Continuous Glucose Monitoring (CGM) Device Market due to a heightened concern with health and safety during the outbreak, which led to a rising demand for devices or solutions that provide the option of trying out health monitoring without having to visit a medical facility. Hospital systems were overwhelmed, and facilities were limited to in-person visits; hence, more patients and healthcare providers considered CGM as a means to manage diabetes from home. Along with the demand for continuous, real-time glucose tracking, another factor driving this demand is the convenience offered by remote monitoring. The transition to telemedicine and home healthcare due to the pandemic gave an increased boost to market growth. The CGM market saw significant growth and innovation during this time.

LATEST TREND

Market Growth Is Driven By Wearable CGM Devices And Mobile Integration

Market for continuous glucose monitoring (CGM) devices is marked by some of the trends that can be traced to non-invasive sensors, better coupling with mobile health apps, and real-time data analytics advancements. One of the most important trends is increasing installation of wearable CGM devices, which allow for continuous monitoring and enhanced comfort for users since they eliminate the pain of frequent finger-prick tests. They now work in sync with smartphones and other health devices to provide instant actionable feedback to users. This trend points to the increasing demand for personalized and convenient solutions for diabetes management.

CONTINUOUS GLUCOSE MONITORING DEVICE MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Sensors and Transmitters & Receivers

• Sensors: The sensors are used in CGM systems since they measure glucose levels in the interstitial fluid. These sensors work by providing the users with real-time data in form of accurate glucose reading all the time. Innovations in sensors are aimed at increasing reliability, decreasing the amount of calibration, and increasing the lifespan of sensors.

• Transmitters & Receivers: Transmitters are tasked with sending the data acquired by the sensor through the air to a receiver that could be a smart phone or a monitor. These components are crucial for making accurate and up to date glucose data available to the users for improved insulin and lifestyle choices. Trends in this segment include integration, easy-to-use input/output devices, and duration of battery power.

By Application

Based on application, the global market can be categorized into TYPE1 Diabetes and TYPE2 Diabetes

• Type 1 Diabetes: CGM devices are necessary for every person with Type 1 diabetes or any other type of diabetes where the patients have to monitor their glucose levels in order to avoid sudden changes in the levels. These devices assist in monitoring insulin therapy and maintaining the best glucose levels hence enhancing the quality of life and preventing complications. A greater need for CGMs in this segment is attributed to the necessity of more accurate and timely control of the disease.

• Type 2 Diabetes: CGM devices are helpful for Type 2 diabetes patients to get an idea of glucose patterns and facilitate better lifestyle and drug management. They are used to monitor blood glucose levels, prevent complications and improve the general wellbeing of a patient. With an increased number of patients with Type 2 diabetes, CGMs become a part of the efficient management of diabetes mellitus.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities, and challenges stating the market conditions:

Driving Factors

Growing Prevalence of Diabetes

The global prevalence of diabetes and the specific types – type 1 and type 2 diabetes – is the major growth stimulant for the Continuous Glucose Monitoring (CGM) Device Market. Due to the increasing number of people diagnosed with diabetes, the need for efficient and easy to use glucose control solutions appears. CGMs advise the patient on the actual time blood glucose levels, and ways of enhancing their control, making it an important instrument in diabetes management.

Advancements in Technology and Wearables

Innovations in the CGM devices include the development of more precise sensors, miniaturization of the sensors and better wireless communication solutions that have boosted market expansion. Such devices are now more convenient for use as they can monitor the patients continuously with little or no discomfort. The advancements in CGMs that allow them to interface with mobile applications and wearable have increased the usability of the devices.

Restraining Factor

High Costs And Insurance Variability Hinder Market Growth And Accessibility

The prohibitive pricing of Continuous Glucose Monitoring Device Market Share is one of the major constraining factors that limit the accessibility of these systems to a wider patient population. Although CGM systems are well established and highly efficient in diabetes management, the cost of the apparatus and recurrent sensor replacements is too high. This makes it harder for many patients especially from low-income regions to afford these pricey devices or seek other cheaper alternatives. Insurance provision varies on the CGM devices and this makes affordability an even larger problem for patients. That is why this technology could not be mainstreamed in the patient population.

Opportunity

Rising Diabetes Cases, Advancements, And Integration Boost CGM Market Growth

Growth opportunities pertaining to Continuous Glucose Monitoring (CGM) Devices come mainly from the ever-rising incidences of diabetes and customer demand for personalized healthcare solutions. As preventive care and management of chronic diseases become the focus of healthcare systems all over the world, CGMs will provide real-time glucose data which can lead to better control and improved patient outcomes. Advances in sensor technology, whereby miniaturization and increasing accuracy and user-friendliness are coming into play, also provide a tremendous opportunity for the market. In fact, by far better integrating CGMs with mobile applications and wearables, users can easily monitor and manage diabetes. It is an added plus which multiplies the opportunities provided by increasing awareness about diabetes management in emerging markets. Therefore, all these factors are seeding major growth in the CGM market in years to come.

Challenge

High Costs And Limited Insurance Coverage Hinder Cgm Market Growth

The high costs associated with these devices and their related consumables are the significant barriers which the Continuous Glucose Monitoring (CGM) Device Market has to face. High prices of CGM systems do cost a fortune upfront and then add in the overhead costs for measures and accessories, pricing them out of the league for patients mainly in low-income areas. This high expense somewhat inhibits the widespread adoption of CGMs, which despite having certain recognized benefits in diabetes management, goes unreached by a section of people. Insurance coverage under a typical policy regarding CGMs varies from individual to individual and makes it an additional limitation on accessibility. Furthermore, the insurance reimbursement process, which is very complicated, discourages the probable user. These affordability and access issues will have to be solved, if at all, for them to be effective in terms of expanding markets.

CONTINUOUS GLUCOSE MONITORING DEVICE MARKET REGIONAL INSIGHTS

Request a Free sample to learn more about this report.

To Know Key Insights of the Market

Request Free Sample

• NORTH AMERICA

Factors such as advanced healthcare, high rates of acceptance to new technologies, and soaring prevalence of diabetes have made North America-continents a notable contributor to the continuous glucose monitoring (CGM) device market. Research and development in this region have increased innovation in the CGM devices, enhancing their accuracy and compatibility with users. The United States accounts for a large chunk of the dominance, which is facilitated by the growing healthcare awareness coupled with technological advancements, with the United States Continuous Glucose Monitoring Device Market showing significant growth. Furthermore, regulations from bodies such as the FDA spur the growth of the market. Also, the growing diabetic population across North America increases the demand for CGM devices significantly. It combines all features that make up-the world leader in the market.

• EUROPE

Important to the Continuous Glucose Monitoring Device Market Growth is Europe, which is well enlightened on management of diabetes and highly endowed with healthcare infrastructures. The region's existing healthcare system serves as the foundation for the establishment of CGM technology in most of the countries such as Germany, the UK and France. Government initiatives on diabetes care with early diagnosis promote development in the market. Additionally, the elderly population that manifests chronic conditions such as diabetes drives the increasing demand for CGM devices. Good and high standards set by European regulatory bodies create a complex of competition with innovation. This makes Europe a key player in the global CGM market.

• ASIA

The Continuous Glucose Monitoring (CGM) Device Market is largely attributed to the populations of diabetics and increasing healthcare awareness within Asia. Countries like China and India which are facing the ramp for lifestyle diseases adding more demand for advanced diabetes care solutions. The region currently shows increased adoption of wearable health technology which is aimed to improve health management efficiency. CGMs provide access to real-time information on glucose tracking for better control. It is also the government support and investments made on healthcare infrastructures. Growth in middle-class population would be another probable reason for increased access to such commodities in emerging markets. Thus, demand with technology adoption and improvement of healthcare is causing a strong expansion of the market all over Asia.

KEY INDUSTRY PLAYERS

Market Growth Is Driven By Innovation, Partnerships, And R&D Investments

The major industry players seem to influence the market of Continuous Glucose Monitoring (CGM) Devices through innovation, risk-sharing alliances, and product development. These key companies stress more on efficiency, convenience, and cost-effectiveness; thereby, the adoption rate among diabetes patients has surged significantly. Innovative solutions, such as linking CGM devices with mobile health and telemedicine, drive the market expansion through these partnerships involving healthcare providers and tech companies. Such innovative approaches can even assist patients and healthcare providers in better data tracking and patient management, making CGM systems eventually more accessible. In addition, investments in research and development augment the market by creating next-generation devices.

LIST OF TOP CONTINUOUS GLUCOSE MONITORING DEVICE COMPANIES

• YUYUE MEDICAL (China)
• Senseonics (Maryland, United States)
• Medtronic (Ireland)
• Dexcom (California, United States)
• Abbott (Illinois, United States)

KEY INDUSTRY DEVELOPMENT

Abbott's FreeStyle Libre CGM Saw 21% Growth, Driving Market Expansion

October 2024: Abbott Laboratories had a record growth in sales of FreeStyle Libre CGM system with organic sales that hit slightly above $1.6 billion, a growth of almost 21%. This growth helped the company’s medical devices unit report $4.75 billion in third-quarter sales — a figure that topped analysts’ forecasts. Abbott expects FreeStyle Libre product line to become $10 billion business by 2028 proving the significance of CGM.

March 2024 – FDA Clears First Over-the-Counter CGM: The U.S. Food and Drug Administration (FDA) approved the Dexcom Stelo Glucose Biosensor System, the first over-the-counter (OTC) continuous glucose monitor. It allows individuals who do not use insulin to track glucose trends without a prescription, improving accessibility and health monitoring options​

February 2024 – NIH Funds Research on Non-Invasive CGM Technologies: The National Institutes of Health (NIH) announced funding for research into non-invasive CGM devices that use sweat or interstitial fluid instead of blood. This initiative aims to enhance patient comfort and reduce the need for sensor insertions​

January 2024 – Medicare Expands Coverage for CGM Devices: The Centers for Medicare & Medicaid Services (CMS) expanded coverage for CGM devices to include more patients with Type 2 diabetes. The updated guidelines now allow non-insulin-dependent individuals with documented hypoglycemia to qualify for reimbursement

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies, and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.